Guo W H, Cao L, Chang L
Department of Respiratory Diseases, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China.
Zhonghua Er Ke Za Zhi. 2019 Oct 2;57(10):792-796. doi: 10.3760/cma.j.issn.0578-1310.2019.10.012.
To study the short-term and long-term efficacy of the non-invasive ventilation treatment in children with spinal muscular atrophy (SMA) and sleep-disordered breathing. This was a prospective research to study the effect of night-time non-invasive ventilation in children with SMA and moderate to severe sleep-disordered breathing during March 2016 to January 2018, from the Pulmonary Department of Capital Institute of Pediatrics Affiliated Children's Hospital. Patients were divided into the treated group (with night-time non-invasive ventilation) and the control group (without ventilator). Sleep breathing pressure titration was suggested to the patients who were prepared to receive non-invasive ventilation. All cases were followed up for one year. Parameters'changes in polysomnography were assessed (paired -test) in titration patients. Frequency of respiratory tract infection during the next year in the patients with and without ventilation was collected and compared (Mann-Whitney -test). Seventeen cases were recruited. The average age was (5.1±2.9) years, 10 cases were boys and 7 cases were girls. In the titration group (8 patients), after non-invasive ventilation, the average apnea hypopnea index was (3.8±2.5) times/h (4.086, 0.005), hypopnea index was (2.4±1.2) times/h (2.779, 0.027), average oxygen saturation during total sleep time was 0.966±0.007 (5.292, 0.001), and the minimum oxygen saturation was 0.906±0.023 (-3.938, 0.006). All the above parameters were significantly improved after treatment. Than before, which was (16.6±9.7) times/h, (7.2±4.7) times/h, 0.946±0.015, 0.786±0.092 respectively. Ventilator mode for the 9 children with long time non-invasive ventilation at home was Bi-level positive airway pressure S/T. The positive airway pressure was set at 8-14 cmH(2)O (1 cmH(2)O=0.098 kPa) in inspiratory phase and 4-6 cmH(2)O in expiratory phase. In the treated group (9 patients), the average frequency of upper respiratory tract infection was 1.0 (0, 3.0) times/year (-2.245, 0.023), the lower respiratory tract infection was 0 (0, 0) times/year (-3.189, 0.001), hospitalization was 0 (0, 0) times/year (-3.420, 0.01), and admission to intensive care unit was 0 (0, 0) times/year (-3.353, 0.029). All the above indexes were significantly decreased compared with the control group (8 patients), which was 3.0 (2.3, 7.0) times/year, 2.0 (1.3, 4.5) times/year, 1.0 (1.0, 4.3) times/year, 0.5 (0, 1.0) times/year respectively. Non-invasive ventilation is efficient to SMA children with sleep-disordered breathing, and also can reduce the incidence of respiratory tract infections for children with SMA.
研究无创通气治疗对脊髓性肌萎缩症(SMA)合并睡眠呼吸障碍患儿的短期和长期疗效。这是一项前瞻性研究,于2016年3月至2018年1月,在首都儿科研究所附属儿童医院呼吸内科,研究夜间无创通气对SMA合并中重度睡眠呼吸障碍患儿的影响。将患者分为治疗组(接受夜间无创通气)和对照组(未使用呼吸机)。对准备接受无创通气的患者进行睡眠呼吸压力滴定。所有病例随访一年。对滴定患者的多导睡眠图参数变化进行评估(配对t检验)。收集并比较通气和未通气患者次年呼吸道感染的频率(曼-惠特尼U检验)。共纳入17例患者。平均年龄为(5.1±2.9)岁,男10例,女7例。滴定组(8例患者)无创通气后,平均呼吸暂停低通气指数为(3.8±2.5)次/小时(P = 4.086,0.005),低通气指数为(2.4±1.2)次/小时(P = 2.779,0.027),总睡眠时间平均血氧饱和度为0.966±0.007(P = 5.292,0.001),最低血氧饱和度为0.906±0.023(P = -3.938, 0.006)。治疗后上述所有参数均有显著改善。治疗前分别为(16.6±9.7)次/小时、(7.2±4.7)次/小时、0.946±0.015、0.786±0.092。9例在家长期无创通气患儿的通气模式为双水平气道正压S/T。吸气相气道正压设置为8 - 14 cmH₂O(1 cmH₂O = 0.098 kPa),呼气相为4 - 6 cmH₂O。治疗组(9例患者)上呼吸道感染平均频率为1.0(0,3.0)次/年(P = -2.245,0.023),下呼吸道感染为0(0,0)次/年(P = -3.189,0.001),住院为0(0,0)次/年(P = -3.420, 0.01),入住重症监护病房为0(0,0)次/年(P = -3.353, 0.029))与对照组(均为8例患者)相比,上述所有指标均显著降低,对照组分别为3.0(2.3,7.0)次/年、2.0(1.3,4.5)次/年、1.0(1.0, 4.3)次/年、0.5(0, 1.0)次/年。无创通气对SMA合并睡眠呼吸障碍患儿有效,还可降低SMA患儿呼吸道感染发生率。